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ABSTRACT
Objectives: To compare the ‘strictly’ active management protocol in women with low risk of postpartum hemorrhage using 
the expectant management protocol with respect to changes in hematologic parameters, uterotonics, blood transfusions, 
or additional interventions.
Material and methods: A randomized controlled prospective trial in which 934 singleton parturients enrolled; 654 were 
randomly assigned to the active and mixed management groups. The primary outcome parameter was the reduction in 
hemoglobin concentrations due to delivery, and the secondary outcome parameters were changes in hemoglobin of more 
than 3 g/dL (∆Hb ≥ 3 g/dL), durations of the third stage of labor, need for additional uterotonic agents, blood transfusions, 
manual removal of the placenta, and surgical evacuation of retained products of conception.
Results: The mean postpartum hemoglobin concentration was significantly higher (P = 0.04) in the active management 
group with a significantly lower reduction (P = 0.03). Falls of hemoglobin levels of more than 3 g/dL (∆Hb ≥ 3g/dL) were 
less common in the active management group though not significantly (P = 0.32). The mean duration of the third stage of 
labor was significantly (P < 0.001) shorter in the active management group. There was no significant difference between 
the two groups with regard to the need for additional uterotonic agents, uterine atony, blood transfusion, manual removal 
of the placenta, surgical evacuation of retained products of conception, and prolonged third stage of labor.
Conclusions: Although active management of the third stage of labor was associated with higher postpartum hemoglobin 
levels, it did not influence the risk of ‘severe postpartum hemorrhage’ in women with low risk of postpartum hemorrhage.
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INTRODUCTION
Approximately 127 000 maternal deaths caused by post-
partum hemorrhage are reported worldwide annually [1]. 
Postpartum hemorrhage remains the leading global cause 
of maternal mortality, accounting for at least one-quarter 
of all maternal deaths [2]. Adequate management of the 
third stage of labor is critical due to the fact that postpartum 
hemorrhage often presents following that stage.
Proper management of the third stage of labor makes 
it possible to avoid or at least alleviate postpartum hemor-
rhage. Active and physiologic management (also known as 
expectant approach) have been defined as the two main 
types of management protocols. Active management con-
sists in early umbilical cord clamping, the use of uterotonic 
agents after birth, controlled cord traction, and uterine 
massage. In contrast, in physiologic management clinicians 
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await the signs of placental separation and allow for the 
placenta to fall by maternal effort or spontaneously, with 
gravity, and do not use uterotonic agents or clamp the 
cord until placental expulsion [3]. The choice of the opti-
mal method remains controversial. Although international 
health organizations recommend the active management 
protocol, especially in hospital settings, trials which support 
physiologic management have also been reported [4–8].
A trial from 14 European countries demonstrated the 
third stage of labor management to have significant inter-
national as well as national variations [9]. Although active 
management is precisely described, it is not always strictly 
applied, and the one which applied is rather nonspecifi-
cally referred to as the ‘mixed’ management, comprising the 
physiologic protocol diluted with one or two constituents 
of an active management [10].
OBJECTIVES
The aim of our study was to compare the expectant man-
agement protocol, as it is applied to women with low-risk of 
postpartum hemorrhage in our clinic, with the ‘strictly’ active 
management protocol, primarily with respect to changes 
in the hematologic parameters. The secondary outcome 
measures were the need for uterotonics, blood transfusions, 
or additional interventions (manual removal of the placenta, 
postpartum curettage).
MATERIAL AND METHODS
This randomized controlled prospective trial was held 
at the Istanbul Bakirkoy Maternity and Children Hospital in 
2010, when approximately 18 000 women gave birth. Lo-
cal Ethics Committee approved of the study (no: 278), and 
the ethics standards of the 1975 Declaration of Helsinki as 
revised in 2000 were followed.
Eligibility criteria were: absence of risk factors for post-
partum hemorrhage; gestational age of 36–42 weeks; 
a singleton pregnancy; live fetus; cephalic presentation; 
expected fetal birth weight of 2500–4500 gm; maternal age 
of < 40 years; parity (min.-max.) 0–3. 
The exclusion criteria were: acute fetal distress, conver-
sion to abdominal delivery during labor, need for labor aug-
mentation, persistent high blood pressure (> 140/90 mm Hg), 
placenta previa, ablatio placenta or uterine bleeding of any 
other cause encountered during pregnancy or labor; pre-
vious C-section; uterine scar; postpartum hemorrhage in 
previous pregnancies; hydramnios; symptoms of maternal 
infection; drug use in labor; abnormal placentation (accreta, 
increta or percreta), coagulation defects, forceps or vacuum 
extraction, hemoglobin concentration of < 8 g/dL; use of 
anticoagulants and tocolytics during pregnancy, multiple 
gestations, any known uterine malformations, and deep 
vaginal lacerations.
The effect of the tested protocol on the reduction in 
hemoglobin concentrations due to delivery was the primary 
outcome measure of this study. In our hospital, mean change 
in hemoglobin concentrations due to delivery is –1.3 g/dL 
using the expectant management protocol in the third stage 
of labor. We tested the hypothesis that ‘active management 
should reduce the mean reduction in hemoglobin levels 
due to delivery by 50%’. At a power level of 80%, the mini-
mum number of patients required was 310 patients in the 
2 groups. Nine hundred thirty-four parturients were initially 
eligible in the stated time period. The women consented 
and were enrolled for the study at the time of admission for 
labor and delivery. We prepared standard forms assigned 
for each group; half were tagged with ‘active management’, 
and the other half with ‘expectant management’. Allocation 
concealment was made using sealed opaque envelopes and 
took place when vaginal delivery was imminent, at the end 
of the second stage of labor. 
The ‘active management of the third stage’ group was 
managed in accordance with the recommendations of the 
World Health Organization (WHO, 2007): 10 IU oxytocin 
intramuscular injection within the first minute after delivery, 
early umbilical cord clamping, and application of the con-
trolled cord traction with uterine massage. The ‘expectant 
management of the third stage’ group was managed as: 
umbilical cord clamping after cord pulsation had slowed 
down, placental separation signs were expected (a sudden 
gush of blood from the vagina, lengthening of the umbilical 
cord into a lower segment, rise of the uterus in the abdo-
men); the placenta was allowed to fall by maternal effort and 
gravity; and a 10 IU oxytocin IM injection was administered 
after placental expulsion. 
We ordered a complete blood count from all patients at 
the onset of labor to report the prepartum hemoglobin and 
hematocrit levels, and measured the duration of the third 
stage of labor. The placenta was removed manually if it did 
not fall after 30 minutes. In both groups, uterine massage 
was performed every 15 minutes until leaving the delivery 
room. If vaginal bleeding was persistent, the patient was 
examined vaginally to check for overlooked lacerations 
of the birth tract, uterine massage was conducted, and 
extra uterotonics were administered in the event that these 
measures were not sufficient. The proportion of patients 
who required extra uterotonics or additional interventions 
was recorded in the two groups for comparison. A complete 
blood count was ordered for all patients 24 hours post-
partum and hemoglobin-hematocrit levels were recorded. 
Our policy was to refrain from postpartum blood transfu-
sions unless the hemoglobin concentrations were lower 
than 6 g/dL, or the patient displayed symptoms and signs 
of hypoxemia while the hemoglobin concentration was 
lower than 8 g/dL at the end of the 24th postpartum hour. 
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In order to compare the two groups in terms of se-
vere postpartum hemorrhage, the results were stratified 
as reductions in hemoglobin levels of more than 3 g/dL 
(∆Hb ≥ 3g/dL), and ∆Hb < 3g/dL caused by blood loss in 
the third stage of labor. Other secondary parameters of 
comparison included prolonged third stage of labor, trans-
fusion requirement, requirement of additional uterotonics, 
additional interventions including manual removal of the 
placenta, and the requirement of additional surgery or curet-
tage. SPSS 15.0 for Windows (SPSS Inc, Chicago, IL, USA) was 
used for statistical analysis. The Kolmogorov-Smirnov test 
was used to ensure normal distribution and equality vari-
ance of continuous variables between the two groups. Stu-
dent’s t-test and non-parametric Mann-Whitney U test were 
used to analyze normal and non-normal distribution data, 
respectively. The Chi-square test was used for categorical 
variables and Fisher’s exact test was used if required. A lin-
ear regression model was defined to identify independ-
ent variables which affected the main output variable, i.e. 
hemoglobin reduction following delivery in our population. 
Factor analysis was then used to ensure that the effects of 
these independent variables were similar in both, the study 
and control groups. These independent predictors were 
then used as covariate factors to compare the study and 
control groups in terms of hemoglobin reduction due to 
delivery, while minimizing the effects of these covariates 
using ANCOVA. The p-value of < 0.05 was considered as 
statistically significant.
RESULTS
A total of 934 parturients in active labor were enrolled 
in the trial (Figure 1). Seventy-eight patients were convert-
ed to abdominal delivery because of fetal distress, cord 
prolapse, placental abruption, and persistent bradycardia 
during the second stage of labor. Labor augmentation was 
used in 138 patients due to delay in the first stage of labor. 
Thirty-seven patients later refused to participate in the trial. 
Five patients experienced bleeding during the first stage 
of labor, and 7 parturients required instrumental delivery. 
Some 669 parturients were randomized into the 2 treat-
ment arms: 333 patients in the first group received active 
management and 336 in the second group were treated 
with the expectant management protocol. Six patients in the 
active management group and 9 in the expectant manage-
Enrollment in the trial (n = 934)
Randomised (n = 669)
Excluded (n = 265)
 • Cesarean delivery (n = 78)
 • Refused to participate (n = 37)
 • Need for labor augmentation (n = 138)
 • Experienced bleeding during the first stage (n = 5)
 • Instrumental delivery (n = 7)
Allocated to the Active Management Group 
(n = 333)
 • Received the allocated intervention (n = 333)
 • Did not receive the allocated intervention (n = 0)
Excluded (n = 6)
Deep vaginal laceration
Analysed (n = 327) Analysed (n = 327)
Excluded (n = 9)
Deep vaginal laceration
Allocated to the Expectant Management Group
(n = 336)
 • Received the allocated intervention (n = 336)
 • Did not receive the allocated intervention (n = 0)
Figure 1. Study flowchart
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ment group were excluded because of deep vaginal lacera-
tions. Thus, 327 patients in the active management group 
and 327 patients in the expectant management group with 
low risk for postpartum hemorrhage were analyzed. There 
were no statistically significant differences between the two 
groups with regard to basic characteristics (age, gestational 
week, body mass index, parity, episiotomy, and mean length 
of labor) (Table 1). 
Table 1. Clinical features of the groups
Expectant
Management Protocol
n = 327
Active
Management Protocol
n = 327
P
Age
Mean (SD)β 25.92 (5.13) 25.98 (5.25) 0.88
Body mass index
Mean (SD)β 27.94 (3.8) 27.55 (3.39) 0.17
Gestational week
Mean (SD)β 39.84 (1.81) 38.74 (1.66) 0.27
Birth weight [g]
Mean (SD)β 3248.9 (315.19) 3316.39 (258.45) 0.34
Length of labor (min.)
Mean (SD)β 328.6 (262.76) 353.43 (282.88) 0.25
Prepartum hemoglobin [g/dL]
Mean (SD)β 11.5 (1.23) 11.59 (1.32) 0.38
Prepartum hematocrit (%)
Mean (SD)β 34.91 (3.48) 35.04 (3.73) 0.62
Episiotomy, n (%)γ 229 (70.03) 226 (69.11) 0.8
Parity, n (%)γ
Nulliparity
Multiparity
 
131 (40.06)
196 (59.94)
 
129 (39.45)
198 (60.55)
0.87
βStudent’s T test or Non-parametric tests; γChi-square test. SD — standard deviation
Table 2. Outcome measures of the study groups
Expectant
Management
n = 327
Active
Management
n = 327
Odds ratio
CI: [5–95%] P
–∆Hb loss ≥ 3 g/dL
Severe postpartum hemorrhage, n (%)γ 16 (4.9) 10 (3.1) 0.73–3.64 0.23
Postpartum 24th hour Hb [g/dL]
Mean (± SD)β 10.09 (0.72) 10.78 (0.68) – 0.04*
∆Hb [g/dL]
Mean (± SD)α 1.62 (0.12) 1.02 (0.23) – 0.03*
Postpartum 24th hour Hct (%)
Mean (±SD)β 30.46 (3.98) 30.94 (4.08) – 0.13
∆Hct (%)
Mean (± SD)β 4.45 (2.89) 4.1 (3.05) – 0.14
Duration of 3. stage (minutes)
Mean (± SD)β 9.26 (4.59) 4.11 (2.32) – < 0.001*
Lengthening of 3. stage (> 30 minutes), n (%)γ 3 (0.9) 2 (0.6) 0.17–3.4 0.65
Additional uterotonic use, n (%)γ 30 (9.17) 27 (8.26) 0.27–1.82 0.68
Manual removal of placenta, n (%)γ 3 (0.92) 2 (0.61) 0.16–3.32 0.65
Curettage, n (%)γ 0 (0) 3 (0.92) NA 0.08
Transfusion, n (%)γ 4 (1.2) 3 (0.91) 0.3–5.9 0.4
Atony, n (%)γ 3 (0.92) 4 (1.22) 0.17–3.34 0.7
βStudent’s T test or Non-parametric tests; γChi-square test; αMultivariable linear regression, factor analysis, ANCOVA; *Statistically significant. ∆Hb — change in the hemoglobin 
concentration; ∆Hct — change in the hematocrit; SD — standard deviation; CI — confidence interval
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There were no statistically significant differences in 
prepartum hemoglobin and hematocrit levels (Table 2). 
Hemoglobin levels following delivery were higher (P = 0.04) 
in the active management group.
A linear regression model was used to define the main 
output variable, the hemoglobin reduction following deliv-
ery in our population (P < 0.001); the independent variables 
were: gravida (B = –0.06; P < 0.01); gestational age, a very 
slight effect (B = 0.04; P = 0.02); and prepartum hemoglobin 
levels (B = 0.09; P = 0.008). Factor analysis revealed that the 
effects of these independent variables were similar in both, 
the study and control groups. These independent predictors 
were then used as covariate factors to compare the study 
and control groups in terms of hemoglobin reduction due 
to delivery, while disregarding these covariates using AN-
COVA. Extracting the effects of these covariates, the choice 
of management protocol was found to be a significant de-
termining factor in predicting hemoglobin reduction, which 
was significantly lower in the active management group: 
(1.02 g/dL ± 0.23 vs. –1.62 g/dL ± 0.12; P = 0.03). 
Whether ‘severe hemorrhage’ could be prevented by the 
management protocol choice was tested using ∆Hb ≥ 3 g/dL 
as the threshold. There was no difference between the two 
groups (3.1% vs. 4.9%; Odds Ratio: 0.61; [0.27–1.37], P = 0.32) 
(Table 3). The third stage was shorter, (9.26 (± 4.59) minutes 
vs. 4.11 (± 2.32) minutes) in the active management group, 
which was statistically significant (P = 0.001) (Table 2). No 
difference was obtained between the two groups with the 
additional use of oxytocin, manual expulsion of placenta, 
curettage, blood transfusion demand, uterine atony, and 
lengthening of the third stage (> 30 minutes) (Table 2). No 
maternal death or requirement for additional surgery was 
observed in either of the two groups.
DISCUSSION
In our study, we found significantly higher mean postpar-
tum hemoglobin levels and lower mean decrements in hemo-
globin levels following delivery in the active management 
group as compared to the expectant management group. 
No positive effect in the prevention of severe postpartum 
hemorrhage was observed. However, it is challenging to de-
fine a decrease in an already low baseline incidence for severe 
postpartum hemorrhage with low-risk patients and limited 
sample sizes. Our findings did not confer ‘any preventive effect 
on the secondary outcome measures of the need for extra 
uterotonics, blood transfusions, or additional interventions.’ 
To the best of our knowledge, our study has been the first to 
compare these protocols in a low-risk population.
The active management protocol in our study group 
differed from the expectant protocol in the control group 
in 3 aspects: the timing of the uterotonic administration, 
umbilical cord clamping, and umbilical cord traction. The 
timing of uterotonic administration was studied by Soltani 
et al., in a meta-analysis and was not found to be significant 
with respect to severe postpartum hemorrhage, amount of 
blood loss, retained placenta, requirement for uterotonics, 
or transfusions [11]. McDonald et al., analyzed the timing 
of umbilical cord clamping in a Cochrane review of 11 trials 
and 2898 patients [12]. Their conclusion was that delaying 
umbilical cord clamping had no effect on the amount of 
blood loss or severe postpartum hemorrhage rates, but 
resulted in higher neonatal hemoglobin levels and increased 
rates of neonatal jaundice. 
With regard to the effect of umbilical cord traction, Gul-
mezoglu et al., compared active management performed 
with and without controlled cord traction in a large WHO 
multi-center trial, which is the largest postpartum bleeding 
surveillance study conducted to date, comprising 23681 par-
turients inclusive of all risk subgroups [13]. In the Gulmezo-
glu study, patients were stratified into two groups according 
to the treatment protocols; the full package and the simpli-
fied packages. In both groups, oxytocin IM was administered 
just after the delivery of the fetus. Controlled cord traction 
was applied in the full package group, whereas placental 
separation was managed expectantly in the simplified pack-
age group. The timing of the postpartum oxytocin injection 
in the expectant management protocol in our study was 
the only prominent variation from its ‘simplified package’ 
counterpart in the Gulmezoglu study, which we made after 
placental separation. The Gulmezoglu trial only showed 
a slight increased risk of severe postpartum hemorrhage 
in cases without controlled cord traction. The study group 
concluded that the main component of active manage-
ment was the use of uterotonics and that controlled cord 
traction could be omitted when skilled birth attendants 
were not available.
Du et al. [14], in a recent meta-analysis of 5 randomized 
controlled trials, similarly reported that umbilical cord trac-
tion decreased postpartum blood loss. However, it fell short 
of preventing severe postpartum hemorrhage (> 1000 cc), 
a need for additional uterotonics, or transfusions. 
Table 3. Change in hemoglobin concentrations ≥ 3 g/dL(α)
(–) (+) Total
Active Management(β) 31796.9%
10
3.1%
327
100%
Expectant Management(ε) 31195.1%
16
4.9%
327
100%
Total 62896%
26
4%
654
100%
(α)Defining severe hemorrhage; Chi-square: P = 0.32; no significant difference 
between the two protocols; (β)The active management of the third stage of labor 
group; (ε)The mixed management protocol for the third stage of labor group
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Deneux-Tharaux et al. [15], published a multi-center 
randomized controlled trial of 4355 patients who were ran-
domly allocated to 2 groups of placental separation with 
cord traction and standard placental expulsion. The primary 
outcome measure was the incidence of severe postpartum 
hemorrhage (> 500 mL). The authors concluded that cord 
traction had no effect. Some secondary outcome measures 
were improved, however, including a shortened third stage of 
labor, and a reduced need for manual removal of the placenta.
Begley et al. [3], compared the active and expectant 
management of the third stage of labor in a Cochrane da-
tabase meta-analysis. This meta-analysis showed that al-
though active management reduced mean blood loss and 
postpartum hemorrhage (> 500 cc), there was no statistically 
significant reduction in severe postpartum hemorrhage (> 
1000 cc) for women at low risk for bleeding. Also, hyper-
tension, pain and discomfort, bleeding after discharging 
the patient, and low birth weight still remained as possible 
disadvantages of active management.
Our study is not without limitations. Having not directly 
measured the amount of blood loss, a reduction of more 
than 3 g/dL (∆Hb ≥ 3 g/dL) in hemoglobin levels at 24 hours 
postpartum was considered to indirectly denote severe 
postpartum hemorrhage (> 1000 ml). Only the analyzer of 
the outcome data was blinded to the study groups because 
the performer could not be blinded to the allocated man-
agement protocol. We did not have data about neonatal 
conditions or rates of hospital readmissions.
The need for additional interventions including curet-
tage, manual removal of the placenta, extra uterotonic ad-
ministration, transfusions or uterine atony rates was similar 
between the two groups. This may be due to the low rates 
of these variables in both groups, and the low-risk popula-
tion being studied. Our data show that besides providing 
a smaller decrement in hemoglobin concentrations due to 
delivery, the active management protocol also shortens the 
duration of the third stage of labor. 
Our findings suggest that if active management of the 
third stage of labor is preferred for low-risk parturients with-
in a level-three care hospital in a developing country, it is 
not likely to provide any benefit beyond reducing the dec-
rement of hemoglobin concentrations caused by delivery.
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